BioTek Services Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • BioTek Services's estimated annual revenue is currently $14.8M per year.(i)
  • BioTek Services's estimated revenue per employee is $336,886

Employee Data

  • BioTek Services has 44 Employees.(i)
  • BioTek Services grew their employee count by -6% last year.

BioTek Services's People

NameTitleEmail/Phone
1
VP Clinical AffairsReveal Email/Phone
2
Director FinanceReveal Email/Phone
3
Director Corporate TrainingReveal Email/Phone
4
Territory ManagerReveal Email/Phone
5
Accounts Receivable ManagerReveal Email/Phone
6
Regional Area ManagerReveal Email/Phone
7
Area ManagerReveal Email/Phone
8
Regional Training ManagerReveal Email/Phone
9
clinical lab specialistReveal Email/Phone
10
Finance Asst.Reveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$17M49-9%N/AN/A
#2
$36.5M14235%N/AN/A
#3
$0.1M6500%N/AN/A
#4
$17.3M6111%N/AN/A
#5
$25.7M9517%N/AN/A
#6
$13.4M442%N/AN/A
#7
$23M7717%N/AN/A
#8
$49.3M14210%N/AN/A
#9
$42.8M1447%N/AN/A
#10
$6.7M268%N/AN/A
Add Company

What Is BioTek Services?

We specialize in providing turnkey allergy testing and immunotherapy treatment solutions for medical offices. BioTek provides everything needed, including staffing, leaving minimal cost to a practice. We also handle all back-office tasks, making the addition seamless. Did you know 1 of 3 people in the U.S. have allergies, according to the CDC? BioTek's partners are able to help more of their patients in-house and generate a substantial revenue stream with very little to no investment. To further explore our allergy program and how it could benefit your practice and patients, please contact us at jvogt@bioteklabs.com - The team at BioTek Labs, LLC

keywords:N/A

N/A

Total Funding

44

Number of Employees

$14.8M

Revenue (est)

-6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.6M447%N/A
#2
$9.5M44-23%N/A
#3
$3.5M440%N/A
#4
$7.1M44N/AN/A
#5
$12.7M44-4%N/A